CN Stock MarketDetailed Quotes

300142 Walvax Biotechnology

Watchlist
  • 10.14
  • -0.13-1.27%
Market Closed Sep 6 15:00 CST
16.22BMarket Cap120.71P/E (TTM)

About Walvax Biotechnology Company

The company was founded in 2001 and 2010, and Watson Biotech was successfully listed on the Shenzhen Stock Exchange, becoming the first company in Yunnan Province to be listed on the China GEM. Watson Biotech always adheres to the main theme of “making people born healthy”, incorporates social responsibility into the company's development strategy and management, takes strict adherence to product quality and safety as its mission, never forgets its original intention, keeps up with the times, and strives to create outstanding achievements worthy of society and the times. The company is a high-tech biopharmaceutical enterprise specializing in R&D, production and sales of biotechnological drugs such as human vaccines, and is in a leading position in the biotechnological drug segment represented by novel vaccines. The company's main products are 13-valent pneumococcal polysaccharide conjugate vaccine, 13-valent pneumococcal polysaccharide conjugate vaccine, group A group C meningococcal polysaccharide conjugate vaccine, group A group C meningococcal polysaccharide vaccine, ACYW135 group meningococcal polysaccharide vaccine, adsorbable human papillomavirus bivalent (type 16/18) vaccine (yeast). Corporate honors: National Accredited Enterprise Technology Center, High-tech Enterprise, National High-tech Industrialization Demonstration Project, 70 years since the establishment of New China, the most growing listed company in biomedicine in the 2021 Chinese Listed Company Reputation List, won the honorary title of “Kunming Industrial Development Contribution Award” and “China Pharmaceutical Independent Innovation Pioneer Enterprise” and the title of “National Technological Innovation Demonstration Enterprise” jointly recognized and awarded by the Ministry of Industry and Information Technology and the Ministry of Finance. The company's “R&D and Major Industrialization of the Novel Pneumococcal Vaccine Series” project won the first prize for scientific and technological progress in Yunnan Province, the company won honorary titles such as China Industry-University-Research Cooperation Innovation Demonstration Enterprise, and Yunnan Key Industry Leading Enterprise (Yunnan High-tech Leading Enterprise).

Company Profile

Short Name-A沃森生物
Symbol-A300142
Company NameWalvax Biotechnology Co.,Ltd.
Listing DateNov 12, 2010
Issue Price95.00
Shares Offered25.00M share(s)
FoundedJan 16, 2001
Legal Representativeyunchun li
General Managerwei yao
Secretaryyuran liu
Accounting FirmDaishin Certified Public Accountants (Special General Partnership)
Securities Representativeyongxiang yang
Legal CounselBeijing Guo Feng (Shanghai) Law Firm
Employees242
Phone0871-68312779
Office AddressNo. 395 Kexin Road, High-tech Zone, Kunming, Yunnan
Zip Code650101
Registered AddressNo. 395 Kexin Road, High-tech Zone, Kunming, Yunnan
Fax0871-68312779
Emailir@walvax.com
Business License530000100012970
BusinessResearch and development of biological agents (excluding managed commodities); introduction, cooperation and development of biological projects; research and development of technical services for biotechnology-related projects; import and export of biological products, biopharmaceuticals and related materials; technology import and export. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • yunchun li
  • Chairman, Executive Director, Core Technical Personnel, Chairman of the Commission on Sustainable Development, Chairman of the Strategy Committee
  • 4.33M
  • shaozhong dong
  • Vice Chairman, Employee Directors, Member of the Strategy Committee
  • 2.53M
  • zhen huang
  • Vice Chairman, Directors, Strategy Committee Members
  • 5.56M
  • runsheng jiang
  • Executive Director, Nomination Committee Members, Strategy Committee Members
  • 3.72M
  • yongwu fan
  • Non-executive Directors
  • 83.70K
  • ganghong sun
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Member of the Commission on Sustainable Development, Nomination Committee Members
  • 114.60K
  • lingbing ceng
  • Independent Directors, Audit Committee Members, Strategy Committee Members, Remuneration and Assessment Committee Members
  • 114.60K
  • jinyu zhu
  • Independent Directors, Remuneration and Assessment Committee Members, Chairman of the Audit Committee
  • 114.60K
  • jianmei zhao
  • Independent Non-Executive Director, Audit Committee Members, Chairman of the Nomination Committee, Member of the Commission on Sustainable Development
  • 114.60K
  • yuran liu
  • Board Secretary
  • 1.46M
  • yongxiang yang
  • Securities Affairs Representative, Director of the Board of Directors Office
  • --
  • shiqing ding
  • Chairman of the Supervisory Board, Auditors
  • 41.80K
  • wei yao
  • President, Marketing Director, Employee Directors
  • 2.53M
  • yunyan wu
  • VP
  • --
  • jing shi
  • VP
  • 1.68M
  • qingtang duan
  • VP
  • 1.38M
  • changxiong wu
  • Chief Financial Officer
  • --
  • yunhua wang
  • Head of Audit Department
  • 749.50K
  • pengfei song
  • Director of Human Resources
  • --
  • yu zhou
  • Party Committee Office Director
  • --
  • ye yan
  • Director of Audit and Inspection, Director of Legal Affairs
  • --
  • xin tong
  • General Manager of R&D and Transformation Center
  • 1.94M
  • yi zhong
  • General Manager of Domestic Marketing BU
  • --
  • hua shi
  • Director of Intelligent Information
  • --
  • chenliang zhou
  • General Manager of Recombinant Protein BU
  • --
  • zhijie zuo
  • General Manager of Quality Management Center
  • --
  • qiongqiong zhang
  • Director of Administration
  • --
  • guoliang fang
  • General Manager of New Business BU Division
  • 1.46M
  • ji shi
  • Employee Supervisors
  • 395.90K
  • wei li
  • General Manager of MRNA Vaccine BU
  • --
  • hongwei yang
  • General Manager of International Marketing BU
  • 122.00K
  • yun geng
  • Employee Supervisors
  • 118.60K
  • lin yuan
  • General Manager of the Registration and Medical Center
  • 2.61M
  • jinlong zhao
  • General Manager of Supply Chain Center
  • --
  • ting yan
  • Employee Directors
  • 333.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg